Education
About Us
Working with TipRanks
Follow Us
Agios Pharma (AGIO)
NASDAQ:AGIO
Earnings Data
Report Date
Feb 12, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-1.95Last Year’s EPS
-1.44Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong financial performance, global regulatory progress, and significant pipeline advancements. However, there are challenges with increased expenses and potential regulatory hurdles related to the REMS program.Company Guidance
PYRUKYND Revenue Growth
Third quarter net PYRUKYND revenue was $12.9 million, an increase of 44% compared to the third quarter of 2024 and a 3% increase compared to the second quarter of 2025.
Global Regulatory Approvals
PYRUKYND received approval for adults with thalassemia in Saudi Arabia and a positive CHMP opinion recommending marketing authorization in Europe for thalassemia treatment.
Strong Financial Position
Agios maintains a strong balance sheet with approximately $1.3 billion in cash and investments, enabling strategic investments in pipeline growth and potential U.S. launches.
Pipeline Progress
Enrollment completed for the Phase IIb trial of Tebapivat in lower-risk MDS, with top line data expected early next year. Progress continues in early-stage programs AG-181 for phenylketonuria and AG-236 for polycythemia vera.
AGIO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AGIO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $41.96 | $43.18 | +2.91% |
Jul 31, 2025 | $37.54 | $37.22 | -0.85% |
May 01, 2025 | $29.69 | $30.94 | +4.21% |
Feb 13, 2025 | $32.81 | $33.30 | +1.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Agios Pharma (AGIO) report earnings?
Agios Pharma (AGIO) is schdueled to report earning on Feb 12, 2026, TBA (Confirmed).
What is Agios Pharma (AGIO) earnings time?
Agios Pharma (AGIO) earnings time is at Feb 12, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AGIO EPS forecast?
AGIO EPS forecast for the fiscal quarter 2025 (Q4) is -1.95.